Tolvaptan API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Produced in:

China

Established in: 2019

MOQ: 1 kg

Employees: 10+

Focused on pharmaceutical industry

Reasonable price for the customers

Full service from R&D stage to commercial stage

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

  • BSE/TSE

  • DMF

  • MSDS

Contact supplier

Replies quickly

Produced in:

Unknown

Established in: 1963

MOQ: -

Employees: 800+

World’s 1st exclusive API distributor

Portfolio of 600+ APIs

>250 clients in Europe

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CoA

  • MSDS

  • GMP

Contact supplier

Replies quickly

Located in:

India

Producer

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

Located in:

China

Produced in:

China

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • coa

Contact supplier

Replies slower than most

Located in:

Belgium

Produced in:

Netherlands

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

Located in:

India

Producer

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • DMF

  • WC

  • CoA

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Tolvaptan API 150683-30-0?

Description:
Here you will find a list of producers, manufacturers and distributors of Tolvaptan. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Tolvaptan 
Synonyms:
Samsca  
Cas Number:
150683-30-0 
DrugBank number:
DB06212 
Unique Ingredient Identifier:
21G72T1950

About Tolvaptan

What can you use it for? Tolvaptan is used to treat low blood sodium levels (hyponatremia) associated with various conditions like congestive heart failure, cirrhosis, and syndrome of inappropriate antidiuretic hormones (SIADH). FDA approved on May 2009.

Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements

Tolvaptan is a type of Vasopressin Antagonists


Vasopressin antagonists belong to the pharmaceutical API (active pharmaceutical ingredient) subcategory used in the treatment of various medical conditions. These compounds target the vasopressin receptor, a key component of the body's hormonal system. By inhibiting the actions of vasopressin, these antagonists modulate fluid balance and exert effects on various physiological processes.

Vasopressin antagonists find applications in the management of hyponatremia, a condition characterized by low levels of sodium in the blood. These compounds work by blocking the vasopressin receptor, which reduces the reabsorption of water in the kidneys, leading to increased urine output and the restoration of sodium balance.

Additionally, vasopressin antagonists show promise in the treatment of conditions such as heart failure and cirrhosis. In heart failure, these agents alleviate symptoms by reducing fluid retention and relieving pressure on the heart. In cirrhosis, they help prevent the accumulation of fluid in the abdomen (ascites) and improve overall liver function.

These pharmaceutical API products undergo rigorous quality control and are manufactured in compliance with Good Manufacturing Practices (GMP) to ensure their safety and efficacy. They are typically developed by pharmaceutical companies and supplied to drug manufacturers for formulation into various dosage forms, such as tablets or injections.

Vasopressin antagonists represent a valuable class of pharmaceutical APIs that offer therapeutic potential for several medical conditions. Ongoing research and development in this field aim to further refine their efficacy and safety profiles, potentially leading to new treatment options for patients.


Tolvaptan (Vasopressin Antagonists), classified under Genitourinary Agents


Genitourinary agents are a category of pharmaceutical active ingredients (APIs) that are specifically designed to target and treat disorders related to the genitourinary system. The genitourinary system encompasses the organs and structures involved in the production, storage, and elimination of urine, as well as the reproductive organs.

These APIs play a crucial role in the treatment of various genitourinary conditions, including urinary tract infections (UTIs), erectile dysfunction, urinary incontinence, benign prostatic hyperplasia (BPH), and other related disorders. They exert their therapeutic effects by interacting with specific receptors or enzymes in the genitourinary system, regulating physiological processes, and restoring normal function.

Some commonly used genitourinary agents include alpha-blockers, which relax the smooth muscles in the prostate and bladder neck, improving urine flow in patients with BPH. Additionally, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) are widely prescribed for erectile dysfunction, as they enhance blood flow to the penile tissues, facilitating erection.

These APIs are typically formulated into various dosage forms, such as tablets, capsules, creams, gels, or injections, allowing for convenient administration to patients. The development and production of genitourinary agents involve stringent quality control measures and compliance with regulatory guidelines to ensure safety, efficacy, and consistent product performance.

In summary, genitourinary agents form a crucial category of pharmaceutical APIs used to treat a range of disorders affecting the genitourinary system. Their targeted mechanisms of action and diverse dosage forms make them valuable tools in improving genitourinary health and enhancing patients' quality of life.



Tolvaptan manufacturers | traders | suppliers

We have 7 companies offering Tolvaptan produced in 4 different countries.

Get in contact with the supplier of your choice:

  • Apino Pharma Co., Ltd. from China, product country of origin China
  • TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
  • Alkem Labs. from India, product country of origin India
  • Utopharm (Shanghai) Company Limited from China, product country of origin China
  • Janssen Pharma from Belgium, product country of origin Netherlands
  • MSN Labs. from India, product country of origin India
  • Hetero Drugs from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.